|
US5505941A
(en)
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
|
US7045313B1
(en)
|
1982-11-30 |
2006-05-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
WO1990014837A1
(en)
|
1989-05-25 |
1990-12-13 |
Chiron Corporation |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
MY109299A
(en)
|
1990-08-15 |
1996-12-31 |
Virogenetics Corp |
Recombinant pox virus encoding flaviviral structural proteins
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
JP3282188B2
(ja)
|
1991-06-27 |
2002-05-13 |
日本電気株式会社 |
半導体メモリ装置
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5871742A
(en)
|
1993-03-31 |
1999-02-16 |
Nippon Zeon Co., Ltd |
Recombinant Avipox virus encoding polypeptide of mycoplasma gallisepticum, and utilized a live vaccine
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
EP1293559B1
(en)
|
1994-01-21 |
2005-07-27 |
Powderject Vaccines, Inc. |
Gas driven gene delivery instrument
|
|
GB9502879D0
(en)
|
1995-02-14 |
1995-04-05 |
Oxford Biosciences Ltd |
Particle delivery
|
|
US6265387B1
(en)
|
1995-10-11 |
2001-07-24 |
Mirus, Inc. |
Process of delivering naked DNA into a hepatocyte via bile duct
|
|
US6451592B1
(en)
|
1996-04-05 |
2002-09-17 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
|
US6465634B1
(en)
|
1996-04-05 |
2002-10-15 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
|
CZ438398A3
(cs)
|
1996-07-01 |
1999-03-17 |
Rhone-Poulenc Rorer S. A. |
Způsob přípravy rekombinantních adenovirů
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
JP2001526900A
(ja)
|
1997-12-23 |
2001-12-25 |
イントロヘーネ ベスローテン フェンノートシャップ |
標的細胞の染色体ｄｎａへの外来遺伝子情報の組み込みに有用な、アデノ随伴ウイルスおよびアデノウイルスのキメラ組換えウイルス
|
|
US6972013B1
(en)
|
1998-07-13 |
2005-12-06 |
Genetronics, Inc. |
Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
|
|
US7922709B2
(en)
|
1998-07-13 |
2011-04-12 |
Genetronics, Inc. |
Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
|
|
US7608273B2
(en)
|
1998-08-12 |
2009-10-27 |
University Of Western Ontario |
Recombinant lentivirus encoding modified GP 120 signal sequences
|
|
AT408615B
(de)
|
1998-09-15 |
2002-01-25 |
Immuno Ag |
Neue influenzavirus-impfstoffzusammensetzung
|
|
JP4693244B2
(ja)
|
1999-03-18 |
2011-06-01 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
組換えアデノ随伴ウイルスのヘルパー無しの生産のための組成物および方法
|
|
AU778698B2
(en)
|
1999-04-29 |
2004-12-16 |
Miltenyi Biotec B.V. & Co. KG |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
GB9923176D0
(en)
|
1999-09-30 |
1999-12-01 |
Smithkline Beecham Biolog |
Novel composition
|
|
AU2001257611A1
(en)
|
2000-04-28 |
2001-11-12 |
Avigen, Inc. |
Polynucleotides for use in recombinant adeno-associated virus virion production
|
|
PL218318B1
(pl)
|
2002-05-16 |
2014-11-28 |
Bavarian Nordic As |
Rekombinowany wirus krowianki Ankara (MVA), zawierająca go komórka, szczepionka lub kompozycja farmaceutyczna, sposób lub zestaw do jego otrzymywania, sekwencja DNA zawierająca genom tego wirusa oraz sposób wykrywania tego wirusa lub komórek nim zainfekowanych
|
|
WO2004028563A1
(en)
|
2002-09-27 |
2004-04-08 |
Genexine Inc. |
A vaccine enhancing the protective immunity to hepatitis c virus using plasmid dna and recombinant adenovirus
|
|
US8287879B2
(en)
*
|
2003-10-16 |
2012-10-16 |
The Regents Of The University Of California |
Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
|
|
WO2006012221A2
(en)
|
2004-06-25 |
2006-02-02 |
The Regents Of The University Of California |
Target cell-specific short interfering rna and methods of use thereof
|
|
WO2006135436A2
(en)
|
2004-10-22 |
2006-12-21 |
University Of Florida Research Foundation, Inc. |
Inhibition of gene expression and therapeutic uses thereof
|
|
US8048404B1
(en)
|
2005-01-04 |
2011-11-01 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles for protein drug delivery
|
|
US7541046B1
(en)
|
2005-01-04 |
2009-06-02 |
Gp Medical, Inc. |
Nanoparticles for protein drug delivery
|
|
US7611690B2
(en)
|
2005-01-04 |
2009-11-03 |
Gp Medical, Inc. |
Nanoparticles for protein drug delivery
|
|
CN103031279B
(zh)
|
2005-04-24 |
2015-11-18 |
赛诺菲巴斯德生物制药有限责任公司 |
重组黄病毒疫苗
|
|
AR054822A1
(es)
|
2005-07-07 |
2007-07-18 |
Sanofi Pasteur |
Emulsion inmuno adyuvante
|
|
CA2635996A1
(en)
*
|
2006-01-11 |
2007-07-19 |
Aerovance, Inc. |
Methods and compositions for treating asthma in human and non human primates
|
|
RU2009140134A
(ru)
*
|
2007-04-23 |
2011-05-27 |
Вайет (Us) |
Способы и композиции для лечения и мониторинга лечения связанных с ил-13 нарушений
|
|
US20120088814A1
(en)
*
|
2009-03-31 |
2012-04-12 |
Isis Pharmaceuticals, Inc. |
Methods of modulating an immune response to a viral infection
|
|
US20120177668A1
(en)
*
|
2009-07-06 |
2012-07-12 |
The Australian National University |
Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor
|